Abstract
How human behaviour has changed over the long term in response to COVID-19-related information, such as the number of COVID-19-infected cases and non-pharmaceutical interventions (NPIs), is under-researched. It is also unclear how the increasing vaccination rates have affected human mobility. We estimate human mobility responses to such COVID-19-related information via the interactive effects model, which controls unobservable human mobility factors, using publicly available daily data on ‘human mobility for retail and recreation’ and ‘residential spent time’ in each Japanese prefecture. The results show that Japanese citizens were generally fearful of an unknown virus in the first wave of infection; however, they gradually habituated themselves to similar infection information in the subsequent waves. Nevertheless, the level of habituation decreased in view of information regarding new variants that differed from the previous ones. In contrast, as for NPIs, it is more plausible to consider human mobility responses to varying requests rather than habituation. We also find that rapid vaccination promotion motivates people to go out. Furthermore, we are the first to identify spatial interaction of infection information and heterogeneous responses during increasing and decreasing phases of infection. The long-term analysis is crucial for evidence-based policymaking during the long-term pandemic and future pandemics.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author gratefully acknowledges financial support from the Japan Society for the Promotion of Science through Grant-in-Aid for Scientific Research (No. 20K13484).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
I have rewritten the Abstract, Introduction, and Discussion. However, the statistical analysis results have stayed the same as the previous version.
Data Availability
The datasets generated during and/or analysed during the current study are available from the author on reasonable request.
